Updated:
Cardiac Insight
Cardiac Insight is a other based in Bellevue, founded 2013; the Altss profile covers its classification, headquarters, registration, AUM band, and key contacts...
Cardiac Insight
Cardiac Insight improves patient care with innovative ECG solutions, helping clinicians deliver accurate, life-saving cardiac diagnostics
General information
Firm type
other
Year founded
2013
Location
Region
North America
Country
United States
City
Bellevue
Corporate office
Bellevue, WA, United States
Principals
Dr. Dave Hadley
Co-Founder
Dr. Vic Froelicher
Co-Founder
Sector focus
Frequently asked questions
Who are the founders and how do they divide responsibilities at Cardiac Insight?
Cardiac Insight was co-founded by Dr. Dave Hadley and Dr. Vic Froelicher. Hadley, a Caltech Ph.D., previously co-founded Sierra Geophysics and focuses on algorithm development and product innovation. Froelicher is a cardiologist who contributed to the Stanford Criteria for ECG interpretation, shaping the clinical framework behind the Cardea 20/20 system (per the firm, 2023).
What are the primary FDA-cleared products and what conditions do they diagnose?
Cardiac Insight's two FDA-cleared products are the Cardea SOLO (cleared 2017) and Cardea 20/20. Cardea SOLO is a 7-day wearable ambulatory ECG sensor with software-assisted analysis for detecting arrhythmias. Cardea 20/20 is a handheld 12-lead ECG system designed to identify hidden cardiac conditions in athletes, using the International Consensus Criteria and achieving a low false-positive rate of ~2% (per the firm, 2023).
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: